Dare Bioscience, Inc. (DARE)

NASDAQ

$0.76

$-0.03

(-3.69%)

Regular Market

Dare Bioscience, Inc. (DARE) Live Price Chart

Last updated: ⁦2026-10-13 13:46:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Dare Bioscience, Inc. (DARE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.76, with a market capitalisation of $15.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.69 to $3.78. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$15.21M
Open	$0.79
Day's High	$79.47
Day's Low	$0.69
Previous Close	$0.75
Volume	42.24K
Average Volume	532.19K
P/E Ratio	--
52-Week High	$3.78
52-Week Low	$0.69
Dividend Yield	--
Earnings Date	--

Dare Bioscience, Inc. (DARE) Stock Price Today

Dare Bioscience, Inc. (DARE) is currently trading at $0.76 as of 2026-10-13 13:45:00, up 0.92% ($0.01) from the previous close of $0.75

During today's regular trading session, DARE has traded between $0.69 and $79.47, with a trading volume of 42.24K shares. The current price is near the lower end of today's range.

Dare Bioscience, Inc. (DARE) 7-Day Stock Price Change

Over the past seven days, Dare Bioscience, Inc. (DARE) moved from $0.84 to $0.76, representing a decline of 10.18% ($0.09).

The stock traded between $0.74 and $0.88 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 118.62 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

DARE 52-Week Price Position

Position in Range: 2.2%

52W Low$0.69

52W High$3.78

DARE is currently trading at $0.76, placing it 2.2% of the way from its 52-week low of $0.69 to its 52-week high of $3.78. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Dare Bioscience, Inc. (DARE)?

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Dare Bioscience, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	24
Exchange	NASDAQ
Company Website	https://www.darebioscience.com

How to Buy Dare Bioscience, Inc. (DARE) Stock on MEXC

Eligible investors can buy real shares of Dare Bioscience, Inc. (DARE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DARE and Place Your Order

Open the RealStocks trading page and search for DARE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Dare Bioscience, Inc. (DARE) stock price today?

Dare Bioscience, Inc. (DARE) is currently trading at $ 0.76, up 0.92% ($0.01) from the previous close of $ 0.75. Intraday prices update in real time during regular trading hours.

2.Is DARE stock going up or down today?

As of 2026-10-13 13:45:00, DARE is trading at $ 0.76, up 0.92% ($0.01) from its previous close of $ 0.75. The stock has traded between $ 0.69 and $ 79.47 during today’s regular session. Past price movements do not guarantee future results.

3.What is DARE pre-market price?

As of 2026-10-13 13:45:00, DARE is trading at $ 0.78 in pre-market trading, up 3.45% ($0.03) from the previous close of $ 0.75. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DARE after-hours price?

As of 2026-10-13 13:45:00, DARE is trading at $ 0.76 in after-hours trading, up 1.32% ($0.01) from the regular-session close of $ 0.75. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DARE stock trading now?

DARE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DARE sit relative to its 52-week high and low?

Over the past 52 weeks, DARE has traded between a low of $ 0.69 and a high of $ 3.78. At $ 0.76, the stock is positioned 2.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Dare Bioscience, Inc. in?

Dare Bioscience, Inc. (DARE) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Dare Bioscience, Inc.'s market capitalisation and where is it listed?

Dare Bioscience, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 15.21M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DARE valued in terms of P/E ratio and EPS?

DARE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.56. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Dare Bioscience, Inc. pay a dividend?

Dare Bioscience, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.